Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy

Cisplatin, which is a chemotherapy drug listed on the World Health Organisation’s List of Essential Medicines, commonly induces dose-limiting side effects including chemotherapy-induced peripheral neuropathy (CIPN) that has a major negative impact on quality of life in cancer survivors. Although adj...

Full description

Bibliographic Details

Published in:	Biomolecules
Main Authors:	Andy Kuo, Laura Corradini, Janet R. Nicholson, Maree T. Smith
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Subjects:	glycine transporter glycine receptor analgesics peripheral pain cisplatin chemotherapy
Online Access:	https://www.mdpi.com/2218-273X/11/7/940